Gestational Diabetes

Insufficient numbers of women who had gestational diabetes during pregnancy are being screened for diabetes in the first year postpartum, according to a retrospective study.

High glycosylated hemoglobin levels in women with gestational diabetes are associated with the development of diabetes in the future, new research indicates.

Study found that when the women’s weight was taken into account, sleep apnea was associated with a doubling of the incidence of gestational diabetes and a fourfold increase in the risk of pregnancy-induced hypertension.

The results of this study suggest that the use of certain types of hormonal contraceptives during the 5 years leading up to a pregnancy may be associated with the risk of developing gestational diabetes.

Minor elevations in glucose during pregnancy are associated with a significantly increased risk of having an infant with an abnormal testicular descent, also known as congenital cryptorchidism, the results of a case-control study suggest.

Only 45% women in the cohort underwent postpartum glucose testing, as recommended.

Women with gestational diabetes can be accurately identified by measuring fasting capillary glucose.

Among women with a family history of type 2 diabetes, those with prior GDM were more likely to have CVD risk factors.

The offspring of women with pregestational diabetes, either type 1 or type 2, are at a three-fold increased risk for perinatal mortality, and a two-fold increased risk for congenital anomalies, compared with the general population.

In women in whom prenatal care is the first medical care they receive, screening for gestational diabetes before they are 24 weeks pregnant could help identify those with pre-gestational diabetes mellitus.